Twist Bioscience stock under pressure after new AI protein redesign partnership

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience slides 1.34% today

Highlights

Twist Bioscience is experiencing short-term bearish pressure but maintains a medium- and long-term bullish bias above key moving averages.
Technical indicators show strong bullish momentum with oversold signals, suggesting selling may be exhausted and upside potential is growing.
Price is expected to consolidate within the $82.50–$92.00 range, with a high-probability upside breakout if resistance at $93.25–$93.48 is surpassed.

The company thanked David Liu and his team for choosing Twist Bioscience DNA to support this work. Details are being clarified.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Short-term seller pressure as price holds above major moving averages

Twist Bioscience ($TWST) is trading at $87.36, which is below both the SMA-20 at $93.25 and the Ichimoku Kijun at $93.48, but above the SMA-50 at $81.11 and the SMA-200 at $51.71. This positioning signals short-term pressure from sellers, while the medium- and long-term bias remains bullish as price holds above the 50- and 200-day moving averages; the Kijun level at $93.48 now serves as immediate resistance. Near-term support sits at the SMA-50 ($81.11) with key support at the SMA-100 ($66.65), while immediate resistance is at the Ichimoku Kijun ($93.48) and further at the SMA-20 ($93.25).

Mixed momentum cues as bullish MACD meets oversold oscillators

MACD on D1 indicates strong bullish momentum, while ADX on D1 suggests a sell bias indicating active directional movement, though D1 RSI near 49 and CCI at -138 flag lingering weakness and oversold conditions. Stoch RSI and BBP confirm sellers currently dominate, but oversold signals are growing. Weekly, Twist Bioscience has fallen $2.91 (3.28%) from the previous close of $90.27, placing it in the lower portion of this week’s range and reflecting a steady decline from recent highs. Weekly volatility stands at 17.52%. In today’s session, the stock slid 1.34%, accentuating the short-term downward pressure.

Sideways consolidation favored amid high probability for rebound

Looking ahead, the expected range for the next week is $82.50 to $92.00, normalized for recent volatility and anchored above the 52-week low of $23.30 but below the yearly peak of $105.41. The probability of a price increase is high (more than 80%) based on Buy signals across W1 MACD, ADX, RSI, and MA-50, while a further decline is less likely. The baseline scenario is for sideways consolidation as the price stabilizes around current levels. A bullish breakout above $93.25–$93.48 could drive attempts toward the $95–$97 zone, while a loss of $81.11 would expose the $76 area.

Earlier, analysts noted that Twist Bioscience remained in a bullish long-term trend while navigating short-term pressures and technical challenges. Building on that outlook, investors should monitor for shifts in momentum that could define the prevailing scenario in the sessions ahead.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.